Fingerprint
Dive into the research topics of 'Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, Bruce E Sands, Gerald Dryden, Xavier Hébuterne, Rupert W Leong, Brian Bressler, Thomas Ullman, Peter L Lakatos, Walter Reinisch, Li-An Xu, Allison Luo
Research output: Contribution to journal › Article › peer-review
24
Citations
(Scopus)